867 HIGHER PRETREATMENT HCV-SPECIFIC CD4+ AND CD8+ T CELLS IN PATIENTS WITH A RAPID VIROLOGICAL RESPONSE AFTER PEGINTERFERON- ALPHA-2A/RIBAVIRIN THERAPY BUT NOT AT WEEK 12 OF THERAPY